Literature DB >> 25917140

Maternal serum progesterone concentration and early conceptus development of bovine embryos produced in vivo or in vitro.

C V Barnwell1, P W Farin1, C S Whisnant1, J E Alexander1, C E Farin2.   

Abstract

The hormone progesterone is essential for proper embryonic development. The objective of this study was to examine the relationship between recipient serum concentrations of progesterone, at the time of embryo transfer and at conceptus recovery, on conceptus development from in vivo- or in vitro-produced embryos. Embryos were produced in vivo by superovulation of Holstein cows (IVO; n = 17) or in vitro with either serum-containing (IVPS; n = 27) or serum-restricted medium (IVPSR; n = 34). Single grade I blastocysts from each embryo production system were transferred into heifers on day 7 of development. Conceptuses were recovered on day 17 of gestation and classified as complete, degenerated, or no conceptus. Compared with the IVO group, in vitro-produced embryos had more (P = 0.055) degenerated conceptuses (IVO, 0%; IVPS, 18.5%; and IVPSR, 20.6%). There were no differences in progesterone concentrations at the time of transfer when recipients received either male or female embryos (P > 0.05). Progesterone concentrations in recipients receiving in vivo-produced embryos were higher (P < 0.05; 3.74 ± 0.4 ng/mL; least-squares mean ± standard error of the mean) on day 7 compared with those receiving in vitro-produced embryos (IVPS, 2.4 ± 0.2; IVPSR, 2.58 ± 0.3 ng/mL). However, there was no difference in progesterone concentration on day 7 between treatment groups for heifers from which short conceptuses (≤194 mm) were recovered on day 17. In contrast, when longer (>194 mm) conceptuses were recovered on day 17, heifers receiving in vitro-produced embryos had lower (P = 0.05) serum concentrations of progesterone on day 7 compared with those receiving in vivo-produced embryos (IVPS, 2.2 ± 0.5; IVPSR, 2.3 ± 0.5; IVO, 3.9 ± 0.5 ng/mL). In conclusion, differences in autonomy may exist between in vitro- and in vivo-produced embryos during the period of conceptus elongation with in vitro-produced embryos relying more on intrinsic factors to influence elongation. Published by Elsevier Inc.

Entities:  

Keywords:  Cattle; Conceptus; Embryo; Embryo transfer; In vitro production; Progesterone

Mesh:

Substances:

Year:  2015        PMID: 25917140     DOI: 10.1016/j.domaniend.2015.03.004

Source DB:  PubMed          Journal:  Domest Anim Endocrinol        ISSN: 0739-7240            Impact factor:   2.290


  5 in total

Review 1.  BOARD INVITED REVIEW: Post-transfer consequences of in vitro-produced embryos in cattle.

Authors:  Alan D Ealy; Lydia K Wooldridge; Sarah R McCoski
Journal:  J Anim Sci       Date:  2019-05-30       Impact factor: 3.159

2.  Form of dietary selenium affects mRNA encoding cholesterol biosynthesis and immune response elements in the early luteal phase bovine corpus luteum.

Authors:  Benjamin R Crites; Sarah N Carr; James C Matthews; Phillip J Bridges
Journal:  J Anim Sci       Date:  2022-07-01       Impact factor: 3.338

3.  Application of multi-omics data integration and machine learning approaches to identify epigenetic and transcriptomic differences between in vitro and in vivo produced bovine embryos.

Authors:  Maria B Rabaglino; Alan O'Doherty; Jan Bojsen-Møller Secher; Patrick Lonergan; Poul Hyttel; Trudee Fair; Haja N Kadarmideen
Journal:  PLoS One       Date:  2021-05-24       Impact factor: 3.240

4.  Comparison of gene expression and mitochondria number between bovine blastocysts obtained <i>in vitro</i> and <i>in vivo</i>.

Authors:  Tatsuo Noguchi; Takuro Aizawa; Yasuhisa Munakata; Hisataka Iwata
Journal:  J Reprod Dev       Date:  2019-11-20       Impact factor: 2.214

5.  Characterization and comparative analyses of transcriptomes for in vivo and in vitro produced peri-implantation conceptuses and endometria from sheep.

Authors:  Xia Wei; Zhang Xiaoling; Miao Kai; Wang Rui; Xu Jing; Guo Min; Wu Zhonghong; Tian Jianhui; Zhang Xinyu; An Lei
Journal:  J Reprod Dev       Date:  2016-03-04       Impact factor: 2.214

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.